Clinical outcomes of fully covered self-expanding metallic stent placement for palliation of incurable esophageal cancer with or without radiotherapy

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: A combination therapy of esophageal stent and chemoradiotherapy (CRT) is currently considered risky for severe complications. The aim of this study was to assess the safety and efficacy of a fully covered self-expandable metallic stent (FCSEMS) placement in palliating incurable esophageal cancer before and/or after CRT. Patients and Methods: We retrospectively reviewed clinical outcomes of 64 incurable advanced esophageal cancer patients with FCSEMS placement. Forty-two of 64 patients had FCSEMS placement with RT. Results: The rate of all of stent-related complications tended to be higher in patients who had RT, although no significant difference was observed. The stent-related deaths occurred in one patient due to hemorrhage after FCSEMS placement in the RTnegative group. Conclusion: Palliation of dysphagia or fistulas with FCSEMS in patients with incurable esophageal cancer before and/or after RT is not associated with an increased risk of life-threatening complications.

Cite

CITATION STYLE

APA

SASAKI, K., OSAKO, Y., URATA, M., NODA, M., TSURUDA, Y., UCHIKADO, Y., … OHTSUKA, T. (2021). Clinical outcomes of fully covered self-expanding metallic stent placement for palliation of incurable esophageal cancer with or without radiotherapy. Anticancer Research, 41(1), 385–389. https://doi.org/10.21873/anticanres.14787

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free